BLUEPRINT MEDICINES CORP shareholders Q3 2023

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
NBW CAPITAL LLC 53,973$2,710,5240.66%
Hood River Capital Management LLC 273,913$13,755,9110.44%
Granahan Investment Management 229,247$11,512,7840.41%
Eventide Asset Management 438,500$22,021,4700.40%
Polar Capital Holdings Plc 1,040,000$52,228,8000.39%
Woodline Partners LP 602,027$30,233,7960.35%
HARBOR CAPITAL ADVISORS, INC. 32,484$1,631,3460.35%
Integral Health Asset Management, LLC 50,000$2,511,0000.35%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 20,000$1,002,2000.34%
EFG Asset Management (North America) Corp. 26,837$1,346,1440.32%
External links

This page lists BLUEPRINT MEDICINES CORP's shareholders in Q3 2023. To view BLUEPRINT MEDICINES CORP's shareholder history, click here.